1-4 of 4
Maurizio Bendandi, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Immunotherapy with LAK Cells and Anti-CD20 Monoclonal Antibodies for Follicular Lymphoma: Enhanced Antibody-Dependent Cell Cytotoxicity of LAK Cells in Association with GA101 Rather Than Rituximab

Carlos Panizo, Susana Inoges, MD, PhD, Ascensión López Díaz de Cerio, Ph D, Ricardo García Muñoz, MD, Fernando Pastor, PhD, Carlos Grande García, MD, Mayte Olave, MD, PhD, Luis Palomera, MD, Jose J. Rifon, MD, Sara Barea, MD, Ana Alfonso, MD, Maurizio Bendandi, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4881.
https://doi.org/10.1182/blood.V120.21.4881.4881
Published: 2012
Journal Articles

Idiotypic Vaccination of Patients with Relapsed Follicular Lymphoma Using a Novel Vaccine Formulation Including a Tobacco Plant-Produced Tumor Specific Idiotype

Maurizio Bendandi, MD, PhD, Carlos Becerra, MD, Joseph Kuhn, MD, Suncica Hukic, Nyla Langford, Taizoon Khokhar, Victor Klimyuk, PhD, Yuri Gleba, PhD, Romy Kandzia, PhD, Frank Thieme, PhD, Franziska Jarczowski, Jens Uwe Kuenstler, PhD, Madhuri Vusirikala, MD, Nora Ku, MD, Robert H. Collins, Jr., MD
Journal: Blood
Blood (2011) 118 (21): 1649.
https://doi.org/10.1182/blood.V118.21.1649.1649
Published: 2011
Journal Articles

Single Agent Bendamustine Is An Effective Pre-Vaccine Treatment for Patients with Relapsed Follicular Lymphoma Undergoing Idiotypic Vaccination

Maurizio Bendandi, MD, PhD, Carlos Becerra, MD, Joseph Kuhn, MD, Suncica Hukic, Nyla Langford, Taizoon Khokhar, Victor Klimyuk, PhD, Yuri Gleba, PhD, Romy Kandzia, PhD, Frank Thieme, PhD, Franziska Jarczowski, Jens Uwe Kuenstler, PhD, Madhuri Vusirikala, MD, Nora Ku, MD, Robert H. Collins, Jr., MD
Journal: Blood
Blood (2011) 118 (21): 2691.
https://doi.org/10.1182/blood.V118.21.2691.2691
Published: 2011
Journal Articles

Clinical and Biological Prognostic Factors Evaluation of Diffuse Large B-Cell Lymphoma Patients Relapsed or Refractory After Previous Line with Rituximab Plus Chemotherapy. Results of the Study PRO-R-IPI (NCT01369784),

Carlos Panizo, MD, Anny Jaramillo, MD, Gonzalo Gutierrez-Garcia, Francisco Javier Díaz, Eva González-Barca, MD, Raquel de Oña, Nerea Castro, Juan Manuel Sancho, María Flor García-Alvarez, Blanca Sanchez-Gonzalez, MD, PhD, Francisco Javier Peñalver, Jimena Cannata-Ortiz, Manuel Espeso, María José Requena, Santiago Gardella, Soledad Durán, Ana Pilar González-Rodríguez, Ricardo García-Muñoz, Maurizio Bendandi, MD, PhD, Dolores Caballero, MD
Journal: Blood
Blood (2011) 118 (21): 3654.
https://doi.org/10.1182/blood.V118.21.3654.3654
Published: 2011